Table 2.

MAE errors for the simulations performed with the mean value parameter sets.

Patient		50	55	68	71	77	86	88	95
Tumour profile: GF 60% HF 30% DF 5%	CKR	$\mathit{MA}{\mathit{E}}_{\mathit{clinical}\mathit{case},\mathit{tumour}\mathit{profile},\mathit{ckr}\mathbf{value}}$ (Equation (15)) (%)
	0	—	—	2.77	—	4.85	2.22	1.70	8.12
	0.05	—	—	4.36	—	7.15	2.23	1.48	6.93
	0.1	—	—	3.88	—	7.19	2.28	2.97	5.83
	0.2	9.72	—	3.16	—	5.80	2.28	1.55	7.04
	0.3	6.50	—	2.97	—	3.03	2.28	1.54	5.49
	0.4	5.46	—	4.74	—	3.60	2.27	—	5.36
	0.5	6.68	6.86	4.55	—	—	2.23	—	5.13
		$\mathit{MA}{\mathit{E}}_{\mathit{clinical}\mathit{case},\mathit{tumour}\mathbf{\text{profile}}}$ (Equation(16)) (%)
		7.09	6.86	3.78	—	5.27	2.26	1.85	6.27
Tumour profile: GF 10% HF 30% DF 5%	CKR	$\mathit{MA}{\mathit{E}}_{\mathit{clinical}\mathit{case},\mathit{tumour}\mathit{profile},\mathit{ckr}\mathit{value}}$ (Equation (15)) (%)
	0	—	—	3.25	5.25	18.00	2.39	—	13.50
	0.05	—	—	3.25	6.00	15.33	1.58	—	13.75
	0.1	—	—	3.25	5.25	16.33	2.13	—	10.50
	0.2	—	—	4.00	5.25	15.33	1.84	—	11.00
	0.3	3.75	6.50	3.75	6.00	13.67	1.91	—	12.25
	0.4	27.75	—	5.75	5.00	—	2.15	—	—
	0.5	17.00	—	5.50	5.50	—	2.07	—	—
		$\mathit{MA}{\mathit{E}}_{\mathit{clinical}\mathit{case},\mathit{tumour}\mathbf{profile}}$ (Equation (16)) (%)
		13.5	6.5	4	5.25	15.67	2.01	—	12.25